...
首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Hypothermic versus normothermic cardiopulmonary bypass in patients with valvular heart disease
【24h】

Hypothermic versus normothermic cardiopulmonary bypass in patients with valvular heart disease

机译:瓣膜性心脏病患者的低温与正常体温体外循环

获取原文
获取原文并翻译 | 示例

摘要

Objective The aim of this study was to test the hypothesis that normothermic cardiopulmonary bypass (CPB) is as effective as hypothermic CPB in terms of cardiac protection (cTnI level) and outcome in patients with valvular heart disease. Design Prospective randomized study. Setting A tertiary cardiothoracic referral center. Participants 140 patients who had valvular heart disease, with/without coronary artery disease, surgically treated under CPB. Interventions The patients were allocated randomly to undergo either hypothermic (temperature [T], 31 C-32 C) or normothermic CPB (T>36 C). Measurements and Main Results The primary endpoint was the dynamics of troponin I. The secondary endpoints were ventilation time, the need for inotropic support, intensive care unit (ICU) and hospital stay durations, complications, and mortality. There were no significant intergroup differences in dynamics of troponin I. Ventilation time was significantly lower in the hypothermic group (6 (5-9) and 8 (5-12); p = 0.01). Conclusions Normothermic CPB in patients with valvular heart disease was as effective as hypothermic perfusion in terms of myocardial protection after the surgery assessed by cTnI release. The short ventilation duration in patients who underwent hypothermic CPB needs to be confirmed in a future investigation.
机译:目的本研究的目的是检验以下假设:就心脏瓣膜病患者的心脏保护(cTnI水平)和预后而言,常温体外循环(CPB)与低温CPB一样有效。设计前瞻性随机研究。设置三级心胸转诊中心。参与者140名患有瓣膜性心脏病,有/无冠心病的患者,在CPB下接受了手术治疗。干预措施患者被随机分配接受低温(温度[T],31 C-32 C)或常温CPB(T> 36 C)。测量和主要结果主要终点为肌钙蛋白I的动力学变化。次要终点为通气时间,需要正性肌力药物支持,重症监护病房(ICU)以及住院时间,并发症和死亡率。肌钙蛋白I动力学之间没有显着的组间差异。低温组的通气时间显着缩短(6(5-9)和8(5-12); p = 0.01)。结论在通过cTnI释放评估的手术后的心肌保护方面,瓣膜性心脏病患者的常温CPB与低温灌注一样有效。接受低温CPB的患者通气时间短,需要在以后的研究中确认。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号